Useful resources |
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease (Cochrane Review) ABSTRACT Background: Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) and darbepoetin alfa. Recently higher haemoglobin (Hb . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |